Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Expression profiling by high throughput sequencing | Mus musculus | Hongjian Jin | |||||
GSE108362 |
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects [RNA-seq]
|
|
41 | Hongjian Jin | Jan 03, 2019 | |||
GSE108364 |
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects
|
|
100 | Hongjian Jin | Jan 03, 2019 | |||
GSE166808 |
Quantitative assessment of transcriptomic differences between ASPcKO and ASPcKOP7cKO flow cytometry-sorted murine FN-RMSs by RNA sequencing
|
|
8 | Hongjian Jin | Aug 24, 2021 | |||
GSE166906 |
Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
|
|
|
29 | Hongjian Jin | Aug 24, 2021 | ||
GSE172221 |
A genetic mouse model of malignant peripheral nerve sheath tumor with postnatal Nf1 and p53 loss recapitulates the histology and transcriptome of human tumors
|
|
|
44 | Hongjian Jin | Mar 24, 2024 | ||
GSE193124 |
Genome-wide mapping of oncogenic pathways and genetic modifiers of chemotherapy using a high-risk hepatoblastoma genetic model
|
|
6 | Hongjian Jin | Jun 22, 2023 | |||
GSE218274 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity
|
|
|
75 | Hongjian Jin | Sep 29, 2023 | ||
GSE218357 |
PAX3-FOXO1 drives tumor formation from multiple lineages [RNA-seq]
|
|
|
31 | Hongjian Jin | Sep 30, 2023 | ||
GSE218358 |
PAX3-FOXO1 drives tumor formation from multiple lineages [scRNA-seq]
|
|
13 | Hongjian Jin | Sep 30, 2023 | |||
GSE240505 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma [RNA-seq]
|
|
|
22 | Hongjian Jin | Mar 04, 2024 | ||
GSE240506 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
|
|
26 | Hongjian Jin | Mar 02, 2024 | ||
GSE240980 |
Cellular fitness of MYC-driven cancer cells to genetic and pharmacologic perturbations in normoxia, hypoxia and 3D
|
|
8 | Hongjian Jin | Jun 26, 2024 | |||
GSE253185 |
Credentialling a c-MYC-driven genetic neuroblastoma model
|
|
5 | Hongjian Jin | Nov 05, 2024 | |||
GSE255205 |
Credentialling a c-MYC-driven genetic neuroblastoma model [RNAseq-NB]
|
|
14 | Hongjian Jin | Nov 05, 2024 |